OpenAI has agreed to acquire Astral, a startup behind widely used Python development tools, in a deal designed to sharpen its Codex coding assistant as competition with Anthropic intensifies. The ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Paris-based company develops an AI solution to automate accounts receivable processes, helping businesses improve cash flow ...

It’s a great, easy way to turn your handwriting into a font, but you can use it to create any typeface you can imagine as long as long as you have the adequate drawing skills. I tried it myself and it ...

Intuit lost 42% of its market cap as AI agents threaten to replace QuickBooks and TurboTax. Here's what the company says agents can't replicate.

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...